Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
32976 | 100 | 33.2 | 91% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2116 | 4671 | ANGIOTENSINOGEN//ANGIOTENSIN CONVERTING ENZYME//ANGIOTENSINOGEN GENE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GPRC5A | Author keyword | 8 | 75% | 6% | 6 |
2 | GNAS1 | Author keyword | 3 | 31% | 9% | 9 |
3 | CELLULAR SIGNALINGCANC | Address | 2 | 67% | 2% | 2 |
4 | GPRC5D | Author keyword | 2 | 67% | 2% | 2 |
5 | 393T C POLYMORPHISM | Author keyword | 1 | 100% | 2% | 2 |
6 | GPRC5B | Author keyword | 1 | 100% | 2% | 2 |
7 | 2Q21 | Author keyword | 1 | 50% | 1% | 1 |
8 | ARHGEF4 | Author keyword | 1 | 50% | 1% | 1 |
9 | ASTELLAS | Author keyword | 1 | 50% | 1% | 1 |
10 | BCL 2 HOMOLOGOUS ANTAGONIST KILLER PROTEIN | Author keyword | 1 | 50% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GPRC5A | 8 | 75% | 6% | 6 | Search GPRC5A | Search GPRC5A |
2 | GNAS1 | 3 | 31% | 9% | 9 | Search GNAS1 | Search GNAS1 |
3 | GPRC5D | 2 | 67% | 2% | 2 | Search GPRC5D | Search GPRC5D |
4 | 393T C POLYMORPHISM | 1 | 100% | 2% | 2 | Search 393T++C+POLYMORPHISM | Search 393T++C+POLYMORPHISM |
5 | GPRC5B | 1 | 100% | 2% | 2 | Search GPRC5B | Search GPRC5B |
6 | 2Q21 | 1 | 50% | 1% | 1 | Search 2Q21 | Search 2Q21 |
7 | ARHGEF4 | 1 | 50% | 1% | 1 | Search ARHGEF4 | Search ARHGEF4 |
8 | ASTELLAS | 1 | 50% | 1% | 1 | Search ASTELLAS | Search ASTELLAS |
9 | BCL 2 HOMOLOGOUS ANTAGONIST KILLER PROTEIN | 1 | 50% | 1% | 1 | Search BCL+2+HOMOLOGOUS+ANTAGONIST+KILLER+PROTEIN | Search BCL+2+HOMOLOGOUS+ANTAGONIST+KILLER+PROTEIN |
10 | CHORDATE DEVELOPMENT | 1 | 50% | 1% | 1 | Search CHORDATE+DEVELOPMENT | Search CHORDATE+DEVELOPMENT |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RAI3 | 9 | 83% | 5% | 5 |
2 | GENE GNAS1 | 8 | 70% | 7% | 7 |
3 | GPRC5A | 6 | 80% | 4% | 4 |
4 | T393C POLYMORPHISM | 2 | 36% | 5% | 5 |
5 | GPRC5B | 1 | 50% | 2% | 2 |
6 | GNAS1 T393C POLYMORPHISM | 1 | 21% | 4% | 4 |
7 | BONE CELLS SAOS 2 | 1 | 50% | 1% | 1 |
8 | REGULATORY PROTEIN ALTERATIONS | 1 | 50% | 1% | 1 |
9 | SQUAMOUS CELL DIFFERENTIATION | 1 | 50% | 1% | 1 |
10 | TRANSCRIPT AA454543 | 1 | 50% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Astellas Drug Discovery Strategy: Focus on Oncology | 2012 | 1 | 17 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CELLULAR SIGNALINGCANC | 2 | 67% | 2.0% | 2 |
2 | STRATEGY PLANNING ADM | 1 | 50% | 1.0% | 1 |
3 | THORAC HEAD NECK MED ONCOL 432 | 1 | 50% | 1.0% | 1 |
4 | CELL DIFFERENTIAT OPTOSIS PATHOP | 0 | 33% | 1.0% | 1 |
5 | PEOPLES HOSP 9 ORAL MAXILLO IAL HEAD N | 0 | 33% | 1.0% | 1 |
6 | TUMOR GROWTH BIOL | 0 | 33% | 1.0% | 1 |
7 | USD MALATTIE RARE | 0 | 33% | 1.0% | 1 |
8 | WM KECK MASS SPE OMETRY | 0 | 33% | 1.0% | 1 |
9 | PHARMAKOGENET | 0 | 13% | 3.0% | 3 |
10 | WTZE | 0 | 20% | 1.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000124683 | GI ALPHA PROTEINS//GI ALPHA PROTEIN//GQALPHA PROTEIN |
2 | 0.0000114256 | PSEUDOHYPOPARATHYROIDISM//ALBRIGHT HEREDITARY OSTEODYSTROPHY//ALBRIGHTS HEREDITARY OSTEODYSTROPHY |
3 | 0.0000104146 | MEMBRANE LIPID THERAPY//MOL CELL BIOMED//MOL CELLULAR BIOMED |
4 | 0.0000100057 | GNB3//ADDUCIN//G PROTEIN BETA 3 SUBUNIT |
5 | 0.0000087077 | PROSTATE STEM CELL ANTIGEN//PROSTATE STEM CELL ANTIGEN PSCA//PSCA |
6 | 0.0000066998 | G ALPHA12//G ALPHA16//G ALPHA 16 |
7 | 0.0000060267 | ADRB2//BETA2 ADRENERGIC RECEPTOR//BETA 2 ADRENERGIC RECEPTOR GENE |
8 | 0.0000056143 | CXCL14//DBC2//BRAK |
9 | 0.0000044889 | ENVIRONMENTAL CIGARETTE SMOKE//STRAIN A J MICE//LUNG TUMORS |
10 | 0.0000044494 | HYPOTHALAMIC BETA ENDORPHIN NEURONS//PSYCHIAT ANAT CELL BIOL//PRENATAL RAT |